Caroline Choi, MD
Family Medicine · Arlington Hts, ILNPI 1063462646
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 453 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,706, 2.4 times the $1,115 reported in 2019. Among family medicine clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 453 payments — averaging $21.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- AstraZeneca$1K
- AbbVie$1K
- Pfizer$791
- Boehringer Ingelheim$455
- plus $3K from 29 others
What the payments were for
- Speaking & faculty fees$320%
- Food & beverage$9,74399%
- Education$521%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 63 | $1,481 |
| Lilly USA, LLC | 72 | $1,352 |
| AstraZeneca | 58 | $1,314 |
| AbbVie(2 entities) | 75 | $1,097 |
| Pfizer | 38 | $791 |
| Boehringer Ingelheim | 8 | $455 |
| Abbott | 5 | $411 |
| Bausch Health US, LLC | 18 | $349 |
| Axsome Therapeutics, Inc. | 6 | $336 |
| Exact Sciences | 15 | $334 |
| Bayer | 12 | $300 |
| IBSA Pharma Inc. | 13 | $210 |
| Biohaven Pharmaceutical Holding Company Ltd. | 8 | $179 |
| Corcept Therapeutics | 6 | $171 |
| Johnson & Johnson | 5 | $135 |
| Amneal Pharmaceuticals LLC | 7 | $126 |
| GSK | 7 | $126 |
| Xeris Pharmaceuticals, Inc. | 6 | $115 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $79 |
| Gilead | 2 | $59 |
| Radius Health, Inc. | 2 | $52 |
| Azurity Pharmaceuticals, Inc. | 2 | $39 |
| Merck | 2 | $37 |
| RGH Enterprises LLC | 1 | $29 |
| Amgen | 2 | $25 |
| Hologic Sales And Service, LLC | 1 | $20 |
| Shire North American Group Inc | 1 | $19 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $14 |
| Cranial Technologies, Inc | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Phadia US Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JARDIANCE$354
- Symbravo$223
- Proclaim IPG$162
- AIRSUPRA$125
- Ozempic$125
- FARXIGA$122
- Wegovy$122
- RYBELSUS$113
- FREESTYLE LIBRE 3$110
- ETERNA$100
How this compares
$9,827 in reported general payments places this provider in the 95th percentile of 4,116 family medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 15 | $14,301 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 30 | $9,593 |
| SynthroidLevothyroxine Sodium | 38 | $2,431 |
| Atorvastatin Calcium | 158 | $1,315 |
| Metoprolol Succinate | 36 | $679 |
| Lisinopril | 85 | $649 |
| Lubiprostone | 12 | $648 |
| Bupropion XlBupropion Hcl | 26 | $636 |
| Levothyroxine Sodium | 65 | $619 |
| Rosuvastatin Calcium | 74 | $596 |
| Amlodipine Besylate | 47 | $581 |
| Losartan Potassium | 47 | $481 |
| Metformin Hcl | 40 | $458 |
| Telmisartan | 16 | $444 |
| Simvastatin | 42 | $345 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,481 | $14,30115 claims |
| PfizerAbrysvo | $791 | $9,59330 claims |
| AbbVieSynthroid | $1,097 | $2,43138 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $126 | $61965 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Arlington Hts
- Frank PhillipsChicago$1.6M
- Peter TothSterling$1.4M
- Bradley TorphyChicago$1.3M
- Jeffrey RoyceRockford$890K
- Anthony AuriemmaWestmont$788K
- Manfred ManGurnee$764K
- Barbara BellarOakbrook Terrace$599K
- Bernie RancheroAltamont$533K
- Sandy GibsonChicago$309K
- Mandy GittlerChicago$204K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.